Daxor Corporation to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America
11. September 2019 08:00 ET
|
Daxor Corporation
NEW YORK, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation Announces a 38 Percent Rise in BVA-100 Cardiology Kit Sales and Net Gain of $498,111 for Six Months in Filing of Form N-CSR for June 30, 2019
04. September 2019 08:00 ET
|
Daxor Corporation
NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation to Exhibit at the Society of Hospital Medicine (SHM) Annual Conference 2019
22. März 2019 08:30 ET
|
Daxor Corporation
NEW YORK , March 22, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation Appoints Robert J. Michel as Chief Financial Officer
28. September 2018 08:30 ET
|
Daxor Corporation
NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation to Exhibit at the 22nd Annual Scientific Meeting of the Heart Failure Society of America
12. September 2018 08:30 ET
|
Daxor Corporation
NEW YORK, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation Announces a 23 Percent Rise in BVA-100 Kit Sales in the Area of Cardiology and Filing of Form N-CSR for June 30, 2018
24. August 2018 08:30 ET
|
Daxor Corporation
NEW YORK, Aug. 24, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations filed a Form N-CSR...
Daxor Corporation Appoints Kathryn A. Kornafel Vice President of Marketing and Commercial Development
12. Juni 2018 08:30 ET
|
Daxor Corporation
NEW YORK , June 12, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an innovative medical instrumentation and biotechnology company focused on blood volume measurement today announces...
Daxor Corporation to Present at the LD Micro 8th Annual Invitational on June 4, 2018
30. Mai 2018 08:30 ET
|
Daxor Corporation
NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an innovative medical instrumentation and biotechnology company focused on blood volume measurement, announced that...
A New Study Published in The Annals of Thoracic Surgery: Daxor’s BVA-100 Device Reveals Unexpected Blood Loss of 38% in Cardiac Surgical Patients Not Detected by Common Test in Use
19. April 2018 09:00 ET
|
Daxor Corporation
New York, NY, April 19, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announces the publication of new...
Daxor Corporation Announces Rise in Kit Sales, New Device Sale, and Filing of Form N-CSR for 2017 (NYSE MKT LLC: DXR)
08. März 2018 12:56 ET
|
Daxor Corporation
New York, NY, March 08, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, filed a Form N-CSR disclosing its...